Neurohk s.r.o.
Choceň 56501
4 studies enrolling now · 15 studies all time
What they study most
Agitation Associated With Alzheimer's Dementia, Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Psychosis, Cervical Dystonia, Chronic Migraine, Early Alzheimer's Disease, Early Alzheimer´s Disease, Episodic Migraine, Migraine, Multiple Sclerosis (MS) Primary Progressive, Parkinson's Disease
Studies at this site
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis — Recruiting now
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults — Recruiting now
- A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults — Recruiting now
- ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults — Running, not enrolling
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
- Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling
- A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease — Running, not enrolling
- A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments — Completed
- Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients — Completed
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease — Completed
- A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early
- A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed